Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., . . . Blakey, D. C. (2013). Challenges and key considerations of the enhanced permeability and retention (EPR) effect for nanomedicine drug delivery in oncology.
Chicago Style CitationPrabhakar, Uma, et al. Challenges and Key Considerations of the Enhanced Permeability and Retention (EPR) Effect for Nanomedicine Drug Delivery in Oncology. 2013.
Cita MLAPrabhakar, Uma, et al. Challenges and Key Considerations of the Enhanced Permeability and Retention (EPR) Effect for Nanomedicine Drug Delivery in Oncology. 2013.
Atenció: Aquestes cites poden no estar 100% correctes.